Medication-induced hyperlipoproteinemia is a condition that results from the decreasing of lipoprotein lipase activity resulting in eruptive xanthomas.[1]: 535
| Medication-induced hyperlipoproteinemia | |
|---|---|
| Specialty | Dermatology |
See also edit
References edit
- ^ James, William D.; Berger, Timothy G.; et al. (2006). Andrews' Diseases of the Skin: clinical Dermatology. Saunders Elsevier. ISBN 978-0-7216-2921-6.
 | This cutaneous condition article is a stub. You can help Wikipedia by expanding it. |